The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Levocarnitine

DRUG

Adefovir dipivoxil

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (15)

10001

Community Research Initiative on AIDS, New York

10011

Saint Vincent's AIDS Ctr, New York

17033

Hershey Med Ctr / Dept of Hematology, Hershey

20037

George Washington Med Ctr, Washington D.C.

21287

Johns Hopkins Univ School of Medicine, Baltimore

60612

Cook County Gen Hosp / Division of Infect Diseases, Chicago

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

85016

Phoenix Body Positive, Phoenix

90027

AIDS Healthcare Foundation Labs, Los Angeles

94114

Davies Med Ctr, San Francisco

98122

Swedish Med Ctr, Seattle

06830

Blick Med Associates, Greenwich

02445

Community Research Initiative, Brookline

02860

Mem Hosp of Rhode Island, Pawtucket

00731

Hosp Regional de Ponce - Area Vieja, Ponce

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00002379 - The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs | Biotech Hunter | Biotech Hunter